Autolus Therapeutics plc (6A3A) — Working Capital to Net Assets Ratio
Autolus Therapeutics plc (6A3A) has a Working Capital to Net Assets ratio of 203.5% as of December 2025. Working capital of €362.48 Million (current assets of €435.92 Million minus current liabilities of €73.44 Million) is measured against net assets of €178.13 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Autolus Therapeutics plc (6A3A) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Autolus Therapeutics plc Working Capital to Net Assets (2017–2025)
This chart shows how Autolus Therapeutics plc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 203.5%, reflecting working capital of €362.48 Million against net assets of €178.13 Million EUR. See Autolus Therapeutics plc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Autolus Therapeutics plc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Autolus Therapeutics plc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Autolus Therapeutics plc worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 203.5% | €362.48 Million | €178.13 Million | €435.92 Million | €73.44 Million | ▲ +63.0 pp |
| 2024 | 140.5% | €600.19 Million | €427.32 Million | €660.93 Million | €60.74 Million | ▼ -66.4 pp |
| 2023 | 206.8% | €230.56 Million | €111.47 Million | €275.30 Million | €44.74 Million | ▲ +79.8 pp |
| 2022 | 127.0% | €379.40 Million | €298.67 Million | €425.77 Million | €46.37 Million | ▲ +25.4 pp |
| 2021 | 101.6% | €318.40 Million | €313.32 Million | €346.95 Million | €28.55 Million | ▲ +23.8 pp |
| 2020 | 77.8% | €163.35 Million | €210.03 Million | €196.98 Million | €33.63 Million | ▼ -10.2 pp |
| 2019 | 88.0% | €224.27 Million | €254.84 Million | €249.26 Million | €24.98 Million | ▲ +5.1 pp |
| 2018 | 82.9% | €211.89 Million | €255.47 Million | €232.97 Million | €21.08 Million | ▼ -13.4 pp |
| 2017 | 96.4% | €137.45 Million | €142.60 Million | €142.48 Million | €5.03 Million | — |